Catalyst
Slingshot members are tracking this event:
FDA approves Gilead Sciences (GILD) Vosevi for the treatment of HCV genotypes 1 through 6
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| GILD | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 18, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Vosevi, Hcv, Genotype 1-6, Fda Approval
